Barchart on MSN2d
Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?
Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...
Cardinal Health raised to buy by Jefferies
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to ...
Fintel on MSN6d
Jefferies Upgrades Cardinal Health (CAH)
Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.
Drug Store News13d
Cardinal Health reports Q2 results, raises fiscal year 2025 outlook
Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...
Cardinal Health price target raised to $136 from $135 at Wells Fargo
Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $136 from $135 and keeps an Equal Weight rating on the shares. The firm ...